Ventum Cap Mkts Predicts Cresco Labs FY2026 Earnings

Cresco Labs Inc. (OTCMKTS:CRLBF) – Stock analysts at Ventum Cap Mkts issued their FY2026 earnings per share estimates for Cresco Labs in a research note issued to investors on Monday, November 11th. Ventum Cap Mkts analyst A. Semple expects that the company will earn ($0.06) per share for the year. Ventum Cap Mkts currently has a “Strong-Buy” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.19) per share.

Several other equities research analysts have also recently issued reports on the company. Needham & Company LLC reissued a “hold” rating on shares of Cresco Labs in a research note on Monday, August 12th. Roth Capital upgraded Cresco Labs to a “strong-buy” rating in a report on Sunday, November 10th. Finally, Cormark cut Cresco Labs from a “moderate buy” rating to a “hold” rating in a research report on Monday. Three research analysts have rated the stock with a hold rating, two have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $2.50.

Cresco Labs Stock Performance

OTCMKTS CRLBF opened at $1.40 on Wednesday. The company has a market cap of $683.40 million, a PE ratio of -7.20 and a beta of 1.88. The stock’s 50 day simple moving average is $1.58 and its 200-day simple moving average is $1.70. Cresco Labs has a 1-year low of $1.02 and a 1-year high of $2.65. The company has a debt-to-equity ratio of 1.76, a current ratio of 2.00 and a quick ratio of 1.30.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.